PE20140865A1 - Inhibidores de la tirosina-quinasa de bruton - Google Patents

Inhibidores de la tirosina-quinasa de bruton

Info

Publication number
PE20140865A1
PE20140865A1 PE2014000220A PE2014000220A PE20140865A1 PE 20140865 A1 PE20140865 A1 PE 20140865A1 PE 2014000220 A PE2014000220 A PE 2014000220A PE 2014000220 A PE2014000220 A PE 2014000220A PE 20140865 A1 PE20140865 A1 PE 20140865A1
Authority
PE
Peru
Prior art keywords
methyl
pyridin
tyrosine kinase
compounds
bruton tyrosine
Prior art date
Application number
PE2014000220A
Other languages
English (en)
Inventor
Christine Brotherton-Pleiss
Saul Jaime-Figueroa
Francisco Javier Lopez-Tapia
Yan Lou
Timothy D Owens
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46690498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140865(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20140865A1 publication Critical patent/PE20140865A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

SE REFIERE A COMPUESTOS HETEROCICLOS DE FORMULA (I) DONDE X ES CH, CH2, N, ENTRE OTROS; R ES H, R1, ENTRE OTROS, EN DONDE R1 ES ARILO, HETEROARILO, CICLOALQUILO, ENTRE OTROS; A, Y, Y1 E Y2 SON CADA UNO CH O N; Y3 ES H O F; Y4 ES Y4a, Y4b, ENTRE OTROS, EN DONDE Y4a ES H O HALOGENO; Y4b ES ALQUILO INFERIOR OPCIONALMENTE SUSTITUIDO CON HALOGENO, HIDROXI, CN, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 6-TERT-BUTIL-8-FLUOR-2-{3-HIDROXIMETIL-4-[1-METIL-5-(1'-METIL-1',2',3',4',5',6'-HEXAHIDRO-[3,4']BIPIRIDINIL-6-ILAMINO)-6-OXO-1,6-DIHIDRO-PIRIDAZIN-3-IL]-PIRIDIN-2-IL}-2H-FTALAZIN-1-ONA; 6-TERT-BUTIL-8-FLUOR-2-(3-HIDROXIMETIL-4-{1-METIL-5-[5-((S)-1-METIL-PIRROLIDIN-2-IL)-PIRIDIN-2-ILAMINO]-6-OXO-1,6-DIHIDRO-PIRIDAZIN-3-IL}-PIRIDIN-2-IL)-2H-FTALAZIN-1-ONA; ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (BTK) SIENDO UTILES EN EL TRATAMIENTO DE ARTRITIS REUMATOIDE, ASMA
PE2014000220A 2011-08-17 2012-08-14 Inhibidores de la tirosina-quinasa de bruton PE20140865A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161524374P 2011-08-17 2011-08-17
US201261649991P 2012-05-22 2012-05-22

Publications (1)

Publication Number Publication Date
PE20140865A1 true PE20140865A1 (es) 2014-07-19

Family

ID=46690498

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014000220A PE20140865A1 (es) 2011-08-17 2012-08-14 Inhibidores de la tirosina-quinasa de bruton

Country Status (22)

Country Link
US (1) US8889682B2 (es)
EP (1) EP2744804B1 (es)
JP (1) JP5823616B2 (es)
KR (1) KR20140052032A (es)
CN (1) CN103748088A (es)
AR (1) AR087543A1 (es)
AU (1) AU2012296888A1 (es)
BR (1) BR112014003582A2 (es)
CA (1) CA2841801A1 (es)
CL (1) CL2014000350A1 (es)
CO (1) CO6842020A2 (es)
CR (1) CR20140027A (es)
EA (1) EA024689B1 (es)
EC (1) ECSP14013212A (es)
HK (1) HK1197060A1 (es)
IL (1) IL230561A0 (es)
MA (1) MA35419B1 (es)
MX (1) MX349372B (es)
PE (1) PE20140865A1 (es)
TW (1) TW201311669A (es)
WO (1) WO2013024078A1 (es)
ZA (1) ZA201400739B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA111756C2 (uk) 2011-11-03 2016-06-10 Ф. Хоффманн-Ля Рош Аг Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
ES2552514T3 (es) 2011-11-03 2015-11-30 Hoffmann-La Roche Ag Compuestos bicíclicos de piperazina
PE20141686A1 (es) 2011-11-03 2014-11-08 Hoffmann La Roche Compuestos de piperazina alquilados como inhibidores de actividad btk
RU2622391C2 (ru) * 2011-11-03 2017-06-15 Ф. Хоффманн-Ля Рош Аг Соединения 8-фторфталазин-1(2н)-она в качестве ингибиторов тирозинкиназы брутона
JP6182593B2 (ja) 2012-04-20 2017-08-16 アドヴィーナス セラピューティクス リミテッド 置換ヘテロ二環化合物、組成物及び医薬並びにそれらの用途
WO2013157021A1 (en) 2012-04-20 2013-10-24 Advinus Therapeutics Limited Bicyclic compounds, compositions and medicinal applications thereof
JP6575950B2 (ja) 2012-07-24 2019-09-18 ファーマサイクリックス エルエルシー Ｂｒｕｔｏｎ型チロシンキナーゼ（Ｂｔｋ）阻害剤に対する耐性を伴う変異
BR112015002590A2 (pt) 2012-08-10 2019-08-06 Boehringer Ingelheim Int compostos heteroaromáticos como inibidores de tirosina cinase de bruton (btk)
WO2014076104A1 (en) * 2012-11-16 2014-05-22 F. Hoffmann-La Roche Ag Inhibitors of bruton's tyrosine kinase
JP6042995B2 (ja) * 2012-11-30 2016-12-14 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ブルトン型チロシンキナーゼの阻害薬
RU2618529C2 (ru) * 2013-03-05 2017-05-04 Ф. Хоффманн-Ля Рош Аг Ингибиторы тирозинкиназы брутона
CN104177338B (zh) * 2013-05-22 2018-04-03 南京勇山生物科技有限公司 一类布鲁顿激酶抑制剂
KR101815360B1 (ko) 2013-07-03 2018-01-04 에프. 호프만-라 로슈 아게 헤테로아릴 피리돈 및 아자-피리돈 아마이드 화합물
KR101742550B1 (ko) 2013-07-26 2017-06-01 카나 바이오사이언스, 인코포레이션 신규 트리아진 유도체
AU2014322239A1 (en) * 2013-09-20 2016-04-14 Carna Biosciences, Inc. Novel triazine derivative
CA2929918C (en) 2013-12-05 2018-01-23 F. Hoffmann-La Roche Ag Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality
EP3042903B1 (en) 2015-01-06 2019-08-14 Impetis Biosciences Ltd. Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof
RS58961B1 (sr) 2015-01-22 2019-08-30 Sanofi Aventis Deutschland Proces proizvodnje 2-[4-(ciklopropankarbonil)fenil]-2-metil-propannitrila
EP3365335B1 (en) 2015-10-23 2024-02-14 Array Biopharma, Inc. 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases
WO2021226261A1 (en) 2020-05-06 2021-11-11 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
WO2023009709A1 (en) * 2021-07-29 2023-02-02 Ajax Therapeutics, Inc. Pyrazolo piperazines as jak2 inhibitors
CN115073299A (zh) * 2022-06-14 2022-09-20 爱斯特（成都）生物制药股份有限公司 一种制备2-氟-3-三氟甲基苯胺的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683064B2 (en) * 2008-02-05 2010-03-23 Roche Palo Alto Llc Inhibitors of Bruton's tyrosine kinase
CN101932573B (zh) * 2008-02-05 2014-06-11 霍夫曼-拉罗奇有限公司 吡啶酮类和哒嗪酮类
CA2728016C (en) * 2008-06-24 2017-02-28 F. Hoffmann-La Roche Ag Novel substituted pyridin-2-ones and pyridazin-3-ones
US8299077B2 (en) * 2009-03-02 2012-10-30 Roche Palo Alto Llc Inhibitors of Bruton's tyrosine kinase
AR082590A1 (es) * 2010-08-12 2012-12-19 Hoffmann La Roche Inhibidores de la tirosina-quinasa de bruton
RU2622391C2 (ru) * 2011-11-03 2017-06-15 Ф. Хоффманн-Ля Рош Аг Соединения 8-фторфталазин-1(2н)-она в качестве ингибиторов тирозинкиназы брутона
CA2853138A1 (en) * 2011-12-05 2013-06-13 Immunomedics, Inc. Therapeutic use of anti-cd22 antibodies for inducing trogocytosis

Also Published As

Publication number Publication date
KR20140052032A (ko) 2014-05-02
CO6842020A2 (es) 2014-01-20
ECSP14013212A (es) 2014-03-31
BR112014003582A2 (pt) 2017-03-14
US8889682B2 (en) 2014-11-18
HK1197060A1 (en) 2015-01-02
AU2012296888A1 (en) 2014-01-23
WO2013024078A1 (en) 2013-02-21
MA35419B1 (fr) 2014-09-01
MX349372B (es) 2017-07-26
EA024689B1 (ru) 2016-10-31
CL2014000350A1 (es) 2014-08-22
EP2744804B1 (en) 2017-05-17
CA2841801A1 (en) 2013-02-21
CR20140027A (es) 2014-03-13
AR087543A1 (es) 2014-04-03
IL230561A0 (en) 2014-03-31
TW201311669A (zh) 2013-03-16
CN103748088A (zh) 2014-04-23
EA201490452A1 (ru) 2014-05-30
ZA201400739B (en) 2016-01-27
US20130045965A1 (en) 2013-02-21
EP2744804A1 (en) 2014-06-25
MX2014001653A (es) 2014-03-21
JP5823616B2 (ja) 2015-11-25
JP2014521734A (ja) 2014-08-28

Similar Documents

Publication Publication Date Title
PE20140865A1 (es) Inhibidores de la tirosina-quinasa de bruton
PE20120081A1 (es) Derivados de 6-tert-butil-8-fluor-2-(2-hidroximetil-3-{1-metil-5-piridin-2-il-amino-6-oxo-1,6-dihidro-piridin-3-il}-fenil)-ftalazin-1-ona como inhibidores de la tirosina-quinasa de bruton
PE20141120A1 (es) Compuestos heterociclicos
PE20090886A1 (es) Nuevos inhibidores de quinasa
PE20141203A1 (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
PE20090775A1 (es) Nuevos derivados de biarilo
PE20110819A1 (es) Compuestos de carbazol carboxamida utiles como inhibidores de cinasa
PE20110237A1 (es) Derivados de ciclohexilamida como antagonistas del receptor del factor de liberacion de corticotropina (crf-1)
EA201690035A1 (ru) Новые циклические производные азабензимидазола, используемые в качестве антидиабетических агентов
CL2012001221A1 (es) Compuestos derivados de 4 -(1h-pirrol-1-il) pirimidin -2-ilamino y 4 -(1h-pirazol-1-il)- pirimidin-2-ilamino, inhibidores de quinasa; un compuesto isomerico; composicion farmaceutica; utiles en el tratamiento del asma, enfermedad pulmonar obstructiva cronica, colitis ulcerante, enfermedad de crohn, bronquitis, dermatitis, entre otras.
PE20140502A1 (es) Pirimidinas sustituidas de diaminocarboxamida y diaminocarbonitrilo, composiciones de las mismas y metodos de tratamiento con las mismas
PE20130279A1 (es) Compuestos heteroarilo nitrogenados
PE20090288A1 (es) Derivados de quinoxalina como inhibidores de la pi3 quinasa
PE20140397A1 (es) Derivados de fluoro-piridinona utiles como agentes antibacterianos
PE20141404A1 (es) Derivados de tieno[3,2-d]pirimidina que tienen actividad inhibidora por las quinasas de las proteinas
PE20141974A1 (es) Compuestos de heterociclilo
PE20141828A1 (es) 6-alquinilo piridinas como mimeticos smac
NZ610713A (en) Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
PE20081800A1 (es) NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA
PE20141283A1 (es) Nuevos derivados biciclicos de dihidroisoquinolin-1-ona
PE20120321A1 (es) Indazoles sustituidos con oxazol como inhibidores de pi3-quinasa
PE20090773A1 (es) Derivados de morfolina pirimidina
ATE457311T1 (de) Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine
PE20120135A1 (es) Piperidinas sustituidas como antagonistas de ccr3
PE20091035A1 (es) Derivados de 2-aminopirimidina

Legal Events

Date Code Title Description
FD Application declared void or lapsed